PBH
$49.36-0.70%
Prestige Consumer Healthcare Inc.Stock · HealthcareRussell 2000 · 0.07% of IWMRussell 3000 · 0.003% of IWVUS Stock Market · 0.003% of VTI
PBH — Prestige Consumer Healthcare Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDEEEEEEEEEEE
30.040.050.060.070.080.0010.0M$49.36—20162019202120242026
2026-10-20
Price$49.36
MA20$49.01
MA50$57.10
Vol2.3M
Key stats#
Price data
- Price
- $49.36
- YTD price return
- -19.99%
- YTD total return
- -19.99%
- Next earnings
- Nov 5, 2026 · Before open
- Market cap
- 2.3B
- Enterprise value
- 4.3B
- Shares outstanding
- 47.4M
- 52W low
- $42.62
- 52W high
- $71.07
- From 52W high
- -30.55%
- From 52W low
- +15.81%
- 52W range
- 24%
Volume
- Rel volume
- 0.88×
- 30D volume
- 612.5K
- 30D $ vol
- 28.8M
Fundamentals
- Sales (ttm)
- 1.1B
- Sales/share
- $23.32
- EPS (ttm)
- $3.57
- FCF (ttm)
- 235.4M
- FCF/share
- $4.97
- Book value/share
- $40.46
- Net margin
- 15.57%
- ROE
- 8.97%
- ROA
- 3.77%
- Debt / equity
- 1.05×
- Current ratio
- 3.23
Growth (CAGR, ttm) · 10Y
- Sales
- -1.36%-0.75%+2.36%+2.98%
- Net income
- -19.26%n/a-0.76%+9.69%
- FCF
- -12.14%+3.65%+2.45%+2.70%
- Shares
- -3.74%-1.48%-1.10%-1.10%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -16.22%n/a+0.22%+10.72%
- Sales/share
- +2.47%+0.74%+3.50%+4.13%
- FCF/share
- -8.72%+5.21%+3.58%+3.84%
- Book value/share
- +7.32%+10.63%+7.42%+11.25%
- Price
- -20.63%-6.13%-3.52%+0.38%
- Total return
- -20.63%-6.13%-3.52%+0.51%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 13.8×
- P/OI (ttm)
- 8.1×
- Fwd P/E
- 9.8×
- P/S (ttm)
- 2.1×
- P/B (mrq)
- 1.2×
- P/FCF (ttm)
- 9.9×
- EV/EBITDA (fy)
- 13.4×
- EV/Sales (ttm)
- 3.9×
- FCF yield (ttm)
- 10.06%
- Buyback yield (realized, 1y)
- 3.74%
- Shareholder yield (realized, 1y)
- 3.74%
- Buyback yield (cash, ttm)
- 5.20%
- Shareholder yield (cash, ttm)
- 5.20%
Vs own 10Y history
- P/E
- 31st
- P/OI
- 24th
- P/S
- 30th
- P/B
- 4th
- P/FCF
- 24th
Bar = where today’s multiple sits in PBH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
-0.70%
5D
+1.77%
1M
+9.76%
3M
-2.08%
YTD
-19.99%
1Y
-20.62%
5Y
-16.40%
Financial statements
Open full PBH financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
